{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T02:59:18Z","timestamp":1648868358172},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1038\/ki.2014.421","type":"journal-article","created":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T17:10:19Z","timestamp":1427821819000},"page":"857","source":"Crossref","is-referenced-by-count":0,"title":["The Authors Reply:"],"prefix":"10.1016","volume":"87","author":[{"given":"Aur\u00e9lien","family":"Lorthioir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9my","family":"Bellien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2014.421_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2014.417","article-title":"Induction of nitric oxide release with nebivolol may improve endothelial dysfunction in polycystic kidney disease","author":"Eroglu","year":"2015","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.421_bb0015","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0140-6736(10)60960-9","article-title":"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial","volume":"376","author":"Ong","year":"2010","journal-title":"Lancet"},{"key":"10.1038\/ki.2014.421_bb0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/157016112798829823","article-title":"Hypertension and endothelial dysfunction: therapeutic approach","volume":"10","author":"Ghiadoni","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1038\/ki.2014.421_bb0025","article-title":"Polycystin deficiency induces dopamine-reversible alterations in flow-mediated dilatation and vascular NO release in humans","author":"Lorthioir","year":"2014","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.421_bb0030","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815302222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815302222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T02:47:35Z","timestamp":1554086855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815302222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0085253815302222"],"URL":"https:\/\/doi.org\/10.1038\/ki.2014.421","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}